New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 6 miu/ml;   - solution for injection - 3miu/0.5ml - active: interferon alfa-2a 6 miu/ml   excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection - roferon-a is indicated for the treatment of basal cell carcinoma, carcinoid syndrome, chronic lymphocytic leukaemia (early stage), chronic myelogenous leukaemia, , condylomata acuminata, cutaneous t cell lymphoma (mycosis fungoides and sezary syndrome), essential thrombocythaemia, hairy cell leukaemia, kaposi's sarcoma associated with aids, malignant melanoma, multiple myeloma, non-hodgkin's lymphoma (low and intermediate grade), renal cell carcinoma (recurrent or metastatic).

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 12 miu/ml;   - solution for injection - 6miu/0.5ml - active: interferon alfa-2a 12 miu/ml   excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection - roferon-a is indicated for the treatment of basal cell carcinoma, carcinoid syndrome, chronic lymphocytic leukaemia (early stage), chronic myelogenous leukaemia, , condylomata acuminata, cutaneous t cell lymphoma (mycosis fungoides and sezary syndrome), essential thrombocythaemia, hairy cell leukaemia, kaposi's sarcoma associated with aids, malignant melanoma, multiple myeloma, non-hodgkin's lymphoma (low and intermediate grade), renal cell carcinoma (recurrent or metastatic).

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - interferon alfa-2a 18 miu/ml;   - solution for injection - 9miu/0.5ml - active: interferon alfa-2a 18 miu/ml   excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection - roferon-a is indicated for the treatment of basal cell carcinoma, carcinoid syndrome, chronic lymphocytic leukaemia (early stage), chronic myelogenous leukaemia, , condylomata acuminata, cutaneous t cell lymphoma (mycosis fungoides and sezary syndrome), essential thrombocythaemia, hairy cell leukaemia, kaposi's sarcoma associated with aids, malignant melanoma, multiple myeloma, non-hodgkin's lymphoma (low and intermediate grade), renal cell carcinoma (recurrent or metastatic).

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

troforte innovations pty ltd - olea europaea, quantity: 1 ml/ml (equivalent: olea europaea, qty 1 g/ml) - liquids - excipient ingredients: flavour - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; helps enhance/promote heat/energy production/thermogenesis ; maintain/support heat/energy production/thermogenesis ; helps enhance/promote/increase vitality ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; maintain/support healthy body tissues ; maintain/support body tissue repair/regeneration ; helps enhance/promote body tissue repair/regeneration ; aids/assists abdominal fat loss ; helps maintain/support healthy body mass index (bmi) ; helps enhance/promote bone health ; maintain/support bone health ; helps enhance/promote bone mass/density ; maintain/support bone mass/density/integrity ; decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve mild rheumatic aches and pains ; decrease/reduce/relieve symptoms of mild

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

troforte innovations pty ltd - olea europaea, quantity: 1 ml/ml (equivalent: olea europaea, qty 1 g/ml) - liquids - excipient ingredients: flavour - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; helps enhance/promote heat/energy production/thermogenesis ; maintain/support heat/energy production/thermogenesis ; helps enhance/promote/increase vitality ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; maintain/support healthy body tissues ; maintain/support body tissue repair/regeneration ; helps enhance/promote body tissue repair/regeneration ; aids/assists abdominal fat loss ; helps maintain/support healthy body mass index (bmi) ; helps enhance/promote bone health ; maintain/support bone health ; helps enhance/promote bone mass/density ; maintain/support bone mass/density/integrity ; decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve mild rheumatic aches and pains ; decrease/reduce/relieve symptoms of mild

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

troforte innovations pty ltd - olea europaea, quantity: 1 ml/ml (equivalent: olea europaea, qty 1 g/ml) - liquids - excipient ingredients: - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; helps enhance/promote heat/energy production/thermogenesis ; maintain/support heat/energy production/thermogenesis ; helps enhance/promote/increase vitality ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; maintain/support healthy body tissues ; maintain/support body tissue repair/regeneration ; helps enhance/promote body tissue repair/regeneration ; aids/assists abdominal fat loss ; helps maintain/support healthy body mass index (bmi) ; helps enhance/promote bone health ; maintain/support bone health ; helps enhance/promote bone mass/density ; maintain/support bone mass/density/integrity ; decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve mild rheumatic aches and pains ; decrease/reduce/relieve symptoms of mild

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - interferon alfa-2a -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - interferon alfa-2a -

Singapura - Inggeris - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - lansoprazole - capsule - 30 mg - lansoprazole 30 mg

Singapura - Inggeris - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - dexlansoprazole - capsule, delayed release - 30mg - dexlansoprazole 30mg